• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

再次肝移植:理论依据与结果

Repeat liver retransplantation: rationale and outcomes.

作者信息

Memeo Riccardo, Laurenzi Andrea, Pittau Gabriella, Sanchez-Cabus Santiago, Vibert Eric, Adam Rene, Azoulay Daniel, Cunha Antonio Sa, Ichai Philippe, Saliba Faouzi, Samuel Didier, Cherqui Daniel, Castaing Denis

机构信息

Centre Hépato-biliaire, Paul Brousse Hospital, Université Paris Sud, Villejuif, France.

HPB Surgery and Transplantation Department, ICMDiM, Hospital Clinic de Barcelona, Barcelona, Spain.

出版信息

Clin Transplant. 2016 Mar;30(3):312-9. doi: 10.1111/ctr.12691. Epub 2016 Feb 9.

DOI:10.1111/ctr.12691
PMID:26780428
Abstract

BACKGROUND

Liver retransplantation remains the only option for recurrent graft failure. The aim of our study is to identify predictive factors involved in patients and graft survival for patients undergoing repeat retransplantation (RRT).

METHODOLOGY

From January 1985 to December 2012, 2940 liver transplantations were performed in 2477 patients at Paul Brousse Hospital, Villejuif, France. All patients who underwent third, fourth, and fifth transplantation were included in the study and retrospectively analyzed.

RESULTS

In the univariate analysis, the factors that were associated with 90-d patient post-operative survival were pre-operative vasopressors support, pre-operative extra hepatic sepsis, primary non-function (PNF) as indication of RRT, recipient's model of end stage liver disease (MELD), urgent RRT, creatinine value at RRT, and prothrombin ratio. The multivariate logistic regression confirmed the role of systemic septic status (OR = 12.8, p = 0.01) and vasopressor drug support (OR = 4.7, p = 0.05) as predictors of post-operative mortality. In the univariate analysis, the factors that were associated with patient 10 yr long-term survival (were vasopressor support, systemic septic patient, PNF as indication of RRT, RRT occurred between 1985 and 1999, recipient's MELD, creatinine value at RRT, and prothrombin ratio. The multivariate logistic regression confirmed the role of systemic septic patient (OR = 6.4, p = 0.03) and the RRT between 1985 and 1999 (OR = 3.6, p = 0.05) as predictors of long-term mortality.

CONCLUSION

RRT represent a valid alternative in selected patients. Selection should be oriented on patients needing third transplant without extra hepatic sepsis and vasoactive drug support at moment of RRT. If necessary, fourth and fifth RRT could be performed with a decision made on case-by-case basis, despite a high post-operative mortality.

摘要

背景

肝再次移植仍是移植失败复发患者的唯一选择。我们研究的目的是确定接受再次肝移植(RRT)患者的患者及移植物存活的预测因素。

方法

1985年1月至2012年12月,法国维勒瑞夫市保罗·布罗塞医院对2477例患者实施了2940例肝移植手术。所有接受第三次、第四次和第五次移植的患者均纳入本研究并进行回顾性分析。

结果

单因素分析中,与术后90天患者存活相关的因素有术前血管升压药支持、术前肝外脓毒症、作为RRT指征的原发性无功能(PNF)、终末期肝病受体模型(MELD)、紧急RRT、RRT时的肌酐值及凝血酶原比率。多因素逻辑回归证实全身脓毒症状态(OR = 12.8,p = 0.01)和血管升压药支持(OR = 4.7,p = 0.05)作为术后死亡率预测因素的作用。单因素分析中,与患者10年长期存活相关的因素有血管升压药支持、全身脓毒症患者、作为RRT指征的PNF、1985年至1999年间发生的RRT、受体的MELD、RRT时的肌酐值及凝血酶原比率。多因素逻辑回归证实全身脓毒症患者(OR = 6.4,p = 0.03)和1985年至1999年间的RRT(OR = 3.6,p = 0.05)作为长期死亡率预测因素的作用。

结论

RRT是特定患者的有效选择。选择应针对RRT时不需要肝外脓毒症和血管活性药物支持的第三次移植患者。如有必要,尽管术后死亡率高,但第四次和第五次RRT可根据具体情况逐案决定是否进行。

相似文献

1
Repeat liver retransplantation: rationale and outcomes.再次肝移植:理论依据与结果
Clin Transplant. 2016 Mar;30(3):312-9. doi: 10.1111/ctr.12691. Epub 2016 Feb 9.
2
Decision for retransplantation of the liver: an experience- and cost-based analysis.肝脏再次移植的决策:基于经验和成本的分析
Ann Surg. 2002 Dec;236(6):713-21; discussion 721. doi: 10.1097/01.SLA.0000036264.66247.65.
3
Liver recipients undergoing hepatic transplantation and subsequent retransplantation: a comparison between clinical characteristics.接受肝移植及后续再次移植的肝脏受体:临床特征比较
Hepatogastroenterology. 2003 Nov-Dec;50(54):2143-8.
4
A single center experience of combined liver kidney transplantation.单中心肝肾联合移植经验。
Clin Transplant. 2009 Dec;23 Suppl 21:102-14. doi: 10.1111/j.1399-0012.2009.01146.x.
5
The impact of renal replacement therapy before or after living donor liver transplantation.肝肾联合移植术前与术后行肾脏替代治疗的影响
Clin Transplant. 2012 Jan-Feb;26(1):143-8. doi: 10.1111/j.1399-0012.2011.01450.x. Epub 2011 Mar 30.
6
Liver retransplantation: report of 80 cases and review of literature.肝脏再次移植:80例报告及文献综述
Hepatobiliary Pancreat Dis Int. 2006 May;5(2):180-4.
7
Liver Retransplantation Associated With Kidney Transplantation for End-stage Liver Graft Disease and Renal Insufficiency: A Morbid Procedure on a Unique Subgroup of Patients.肝移植联合肾移植治疗终末期肝移植供体疾病和肾功能不全:一种针对独特亚组患者的高风险手术。
Transplantation. 2020 Jul;104(7):1403-1412. doi: 10.1097/TP.0000000000003035.
8
Risk factors in liver retransplantation: a single-center experience.肝脏再次移植的风险因素:单中心经验
Transplant Proc. 2011 May;43(4):1110-3. doi: 10.1016/j.transproceed.2011.01.141.
9
A Multicenter Japanese Survey Assessing the Long-term Outcomes of Liver Retransplantation Using Living Donor Grafts.一项多中心日本调查评估使用活体供肝进行肝再移植的长期结果。
Transplantation. 2020 Apr;104(4):754-761. doi: 10.1097/TP.0000000000002958.
10
Cardiac retransplantation: is it justified in times of critical donor organ shortage? Long-term single-center experience.心脏再次移植:在供体器官严重短缺时期是否合理?单中心长期经验。
Eur J Cardiothorac Surg. 2008 Dec;34(6):1185-90. doi: 10.1016/j.ejcts.2008.06.044. Epub 2008 Aug 9.

引用本文的文献

1
Indications and Outcomes with Liver Retransplantation in 2025.2025年肝脏再次移植的适应症与结果
Dig Dis Sci. 2025 Jan;70(1):29-38. doi: 10.1007/s10620-024-08741-x. Epub 2024 Nov 22.
2
Outcomes of Adult Liver Retransplantation: A Canadian National Database Analysis.成人肝移植再移植的结果:加拿大国家数据库分析。
Can J Gastroenterol Hepatol. 2022 Mar 22;2022:9932631. doi: 10.1155/2022/9932631. eCollection 2022.
3
Association between hospital liver transplantation volume and mortality after liver re-transplantation.医院肝移植量与肝再移植后死亡率的关系。
PLoS One. 2021 Aug 5;16(8):e0255655. doi: 10.1371/journal.pone.0255655. eCollection 2021.
4
Study of re-transplantation and prognosis in liver transplant center in Iran.伊朗肝脏移植中心再次移植及预后研究
Gastroenterol Hepatol Bed Bench. 2021 Summer;14(3):237-242.
5
The Liver Retransplantation Risk Score: a prognostic model for survival after adult liver retransplantation.肝移植后再移植风险评分:成人肝移植后生存的预后模型。
Transpl Int. 2021 Oct;34(10):1928-1937. doi: 10.1111/tri.13956. Epub 2021 Jul 16.